Robert Bindert Huizinga Net Worth & Insider Trades
Robert Bindert Huizinga - EVP Research, Aurinia Pharmaceuticals Inc
What is Robert Bindert Huizinga's Net Worth?
The current estimated net worth of Aurinia Pharmaceuticals Inc's EVP Research, Robert Bindert Huizinga, is estimated to be about $6.54M . Robert Bindert Huizinga owns about 69,379 units of Aurinia Pharmaceuticals Inc common stock. In the last year at Aurinia Pharmaceuticals Inc, Robert Bindert Huizinga has sold an estimated value of $5.48M worth.
What is Robert Bindert Huizinga's Past Insider Trading?
Robert Bindert Huizinga's largest purchase order was 95,000 units , worth over $304K on October 26, 2021. Robert Bindert Huizinga's largest sale order was 130,000 units , worth over $3.87M on October 26, 2021. In total, Robert Bindert Huizinga has made about 6 transactions over a year of their time at Aurinia Pharmaceuticals Inc. Robert Bindert Huizinga usually trades in September, with the busiest year in 2021. The most recent transaction was a sale order of 4,849 units , worth over $58.24K on March 4, 2022.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Robert Bindert Huizinga
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Robert Bindert Huizinga's Salary in 2020?
As EVP Research of Aurinia Pharmaceuticals Inc, Robert Bindert Huizinga has a total base salary of $72,081 . Robert Bindert Huizinga received compensation valued at about $3,562,379 in 2020 after becoming EVP Research. The vast majority of their compensation came in the form of a bonus of $75,684 , stock awards of $461,040 , option awards of $2,907,909 , other earnings, plans or compensations of $43,249 , and other compensation of $2,416 .
What is Robert Bindert Huizinga's' Mailing Address?
- Mailing address is #1203-4464 Markham Street Victoria A1 BC V8Z7X8 British Columbia, Canada
Aurinia Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Peter Greenleaf | 2020 | $673,400 | - | $1,534,992 | $7,753,906 | $707,070 | $9,500 | $10,678,868 |
| Peter Greenleaf | 2019 | $438,258 | $250,000 | - | $4,176,172 | $368,137 | $4,063 | $5,236,630 |
| Peter Greenleaf | 2018 | - | - | - | - | - | - | - |
| Joe Miller | 2020 | $279,545 | $162,898 | $461,040 | $2,639,722 | $167,727 | $4,100 | $3,715,032 |
| Joe Miller | 2019 | - | - | - | - | - | - | - |
| Joe Miller | 2018 | - | - | - | - | - | - | - |
| Dennis Bourgeault | 2020 | $88,426 | - | - | $399,825 | $121,992 | $93,472 | $703,715 |
| Dennis Bourgeault | 2019 | $270,145 | - | - | $180,784 | $126,205 | $3,713 | $580,847 |
| Dennis Bourgeault | 2018 | $242,969 | - | - | $351,432 | $86,220 | - | $680,621 |
| Max Colao | 2020 | $354,167 | $153,125 | $461,040 | $3,664,488 | $212,500 | - | $4,845,320 |
| Max Colao | 2019 | - | - | - | - | - | - | - |
| Max Colao | 2018 | - | - | - | - | - | - | - |
| Max Donley | 2020 | $383,320 | - | $461,040 | $2,249,253 | $239,575 | $4,615 | $3,337,803 |
| Max Donley | 2019 | $168,299 | - | - | $598,154 | $177,600 | $1,850 | $945,903 |
| Max Donley | 2018 | - | - | - | - | - | - | - |
| Stephen Robertson | 2020 | $72,081 | $75,684 | $461,040 | $2,907,909 | $43,249 | $2,416 | $3,562,379 |
| Stephen Robertson | 2019 | - | - | - | - | - | - | - |
| Stephen Robertson | 2018 | - | - | - | - | - | - | - |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1600620/000162828021009686/auriniapharmaceuticalsinc2.htm
What are Aurinia Pharmaceuticals Inc's Past Insider Trades?
Aurinia Pharmaceuticals Inc's most recent insider trade came on May 23, 2023 by David R.W. Jayne M.D. who sold 8,733 units worth $98.33K . In the last 2 years, insiders at Aurinia Pharmaceuticals Inc have sold an estimated value of $33.6M and bought an estimated value of $6.39M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Michael Robert Martin, Chief Business Officer, Neil Solomons, Chief Medical Officer, and George M. Milne Jr., Ph.D., Director .
Aurinia Pharmaceuticals Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||